These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34250761)

  • 1. Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulfate).
    Lierheimer S; Beck O; Keller T; Monticelli FC; Böttcher M
    Drug Test Anal; 2021 Oct; 13(10):1743-1748. PubMed ID: 34250761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.
    Grabenauer M; Moore KN; Bynum ND; White RM; Mitchell JM; Hayes ED; Flegel R
    J Anal Toxicol; 2018 Jul; 42(6):392-399. PubMed ID: 29554298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS.
    Grabenauer M; Bynum ND; Moore KN; White RM; Mitchell JM; Hayes ED; Flegel R
    J Anal Toxicol; 2018 Mar; 42(2):115-125. PubMed ID: 29186453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid.
    Jones J; Tomlinson K; Moore C
    J Anal Toxicol; 2002 Apr; 26(3):171-5. PubMed ID: 11991534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of hydrocodone in hair.
    Moore C; Feldman M; Harrison E; Rana S; Coulter C; Kuntz D; Agrawal A; Vincent M; Soares J
    J Anal Toxicol; 2006; 30(6):353-9. PubMed ID: 16872564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
    Cone EJ
    Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens.
    Presley L; Lehrer M; Seiter W; Hahn D; Rowland B; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS; Cone EJ
    Forensic Sci Int; 2003 Apr; 133(1-2):22-5. PubMed ID: 12742685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
    Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
    J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair analysis for opiates: hydromorphone and hydrocodone as indicators of heroin use.
    Madry MM; Bosshard MM; Kraemer T; Baumgartner MR
    Bioanalysis; 2016 May; 8(9):953-64. PubMed ID: 27067523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing.
    Böttcher M; Lierheimer S; Peschel A; Beck O
    Drug Alcohol Depend; 2019 May; 198():136-139. PubMed ID: 30927716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids.
    Panwala V; Thorn E; Amiri S; Socias ME; Lutz R; Amram O
    Am J Drug Alcohol Abuse; 2023 Sep; 49(5):597-605. PubMed ID: 37433122
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory analysis of remotely collected oral fluid specimens for opiates by immunoassay.
    Niedbala RS; Kardos K; Waga J; Fritch D; Yeager L; Doddamane S; Schoener E
    J Anal Toxicol; 2001; 25(5):310-5. PubMed ID: 11499883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.
    Liu HC; Lee HT; Hsu YC; Huang MH; Liu RH; Chen TJ; Lin DL
    J Anal Toxicol; 2015; 39(6):472-80. PubMed ID: 25935159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of opiates in biological human samples by liquid chromatography-tandem mass spectrometry].
    Xiang P; Shen M; Shen BH; Ma D; Bu J; Jiang Y; Zhuo XY
    Fa Yi Xue Za Zhi; 2006 Feb; 22(1):52-4, 57. PubMed ID: 16524188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration.
    Barnes AJ; Kim I; Schepers R; Moolchan ET; Wilson L; Cooper G; Reid C; Hand C; Huestis MA
    J Anal Toxicol; 2003 Oct; 27(7):402-7. PubMed ID: 14606992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS.
    Coles R; Kushnir MM; Nelson GJ; McMillin GA; Urry FM
    J Anal Toxicol; 2007; 31(1):1-14. PubMed ID: 17389078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.